Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Vycor Medical (VYCO) Inventory (2016 - 2025)

Vycor Medical has reported Inventory over the past 16 years, most recently at $159202.0 for Q4 2025.

  • Quarterly Inventory rose 8.98% to $159202.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $159202.0 through Dec 2025, up 8.98% year-over-year, with the annual reading at $159202.0 for FY2025, 8.98% up from the prior year.
  • Inventory was $159202.0 for Q4 2025 at Vycor Medical, down from $167415.0 in the prior quarter.
  • Over five years, Inventory peaked at $267542.0 in Q3 2022 and troughed at $146084.0 in Q4 2024.
  • The 5-year median for Inventory is $204602.5 (2022), against an average of $203274.6.
  • Year-over-year, Inventory increased 23.34% in 2021 and then crashed 37.61% in 2024.
  • A 5-year view of Inventory shows it stood at $207521.0 in 2021, then rose by 19.93% to $248874.0 in 2022, then dropped by 5.92% to $234145.0 in 2023, then crashed by 37.61% to $146084.0 in 2024, then increased by 8.98% to $159202.0 in 2025.
  • Per Business Quant, the three most recent readings for VYCO's Inventory are $159202.0 (Q4 2025), $167415.0 (Q3 2025), and $156033.0 (Q2 2025).